Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.75% slipped 0.80% to $165.25 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.01% falling 1.10% to 4,482.73 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.03% falling 0.89% to 34,715.39. This was the stock's eighth consecutive day of losses. Johnson & Johnson closed $14.67 below its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +3.25% fell 0.86% to $395.26, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.59% fell 0.66% to $80.75, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +3.59% rose 0.95% to $54.05. Trading volume (5.8 M) remained 1.7 million below its 50-day average volume of 7.5 M.